{
  "created_at": "Wed Jul 28 12:38:39 +0000 2021",
  "id_str": "1420351349229752322",
  "full_text": "Pfizer raised its full-year forecast for sales of its Covid-19 vaccine to about $33.5 billion, a nearly 30% increase https://t.co/GqX0vsDBUX",
  "display_text_range": [
    0,
    140
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/GqX0vsDBUX",
        "expanded_url": "https://on.wsj.com/3f5Lbtc",
        "display_url": "on.wsj.com/3f5Lbtc",
        "indices": [
          117,
          140
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 44,
  "favorite_count": 67,
  "possibly_sensitive": false,
  "original_created_at": "Wed Jul 28 11:52:05 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社は、Covid-19ワクチンの売上高の通期見通しを、30％近く増加した約335億ドルに引き上げました。https://t.co/GqX0vsDBUX"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司将其Covid-19疫苗的全年销售预测提高到约335亿美元，增长近30% https://t.co/GqX0vsDBUX"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司將其Covid-19疫苗的全年銷售預測提高到約335億美元，增長近30% https://t.co/GqX0vsDBUX"
    }
  ]
}